Kazia Therapeutics talks positive pre-clinical data for EVT801 By: TheNewswire.com December 06, 2022 at 11:45 AM EST Contact DetailsProactive InvestorsJonathan Jackson+61 413 713 744Jonathan@proactiveinvestors.com